Related Experiment Video
Updated: Dec 16, 2025

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major
Ning Sun1,2, Chunxia Yang1, Xiaoting He1,3
1Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Background:
Patients suffering from major depressive disorder (MDD) commonly demonstrate lower performance across multiple cognitive domains. Cognitive impairment is an intrinsic characteristic of MDD status and is often influenced by genetic factors. microRNAs (miRNAs or miRs) have been shown to have important implications in the etiology of MDD. Therefore, we aimed to identify and analyze the impact of expression and genetic variation of miR-34b/c on cognitive dysfunction in MDD.
Methods:
First, we analyzed miR-34c-5p expression in 48 cases of MDD and 54 healthy controls in a Chinese population using qRT-PCR. We assessed the relationship between the level of miR-34c-5p expression and cognitive performance by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Trail Making Test (TMT). Second, in order to characterize allelic effects of miR-34b/c on cognitive performance in MDD patients, we performed genetic association analysis of single-nucleotide polymorphism (SNP) loci of the MIR34B/C genes with cognitive function in a second group consisting of 531 MDD patients and 267 healthy controls.
Results:
We found a significant negative correlation between the level of miR-34c-5p expression and both the language and delayed memory index scores in patients with MDD. We also found a significant positive correlation between the level of miR-34c-5p expression and the time required to complete tests A and B of the TMT. The interaction between the rs2187473 genotype and the disease was significant for both immediate memory and delayed memory. In the patient group, the rs2187473 CC genotype was significantly associated with higher performance on immediate memory (F = 6.683, p < 0.05) and delayed memory tasks (F = 4.221, p < 0.05).
Conclusion:
Our findings suggest that changes in miR-34c expression level have important impacts on cognitive function in patients with MDD. In particular, the polymorphism rs2187473 is a potential genetic risk factor for cognitive function in MDD, which may be of clinical use.
Insights
Lower miR-34c expression correlates with cognitive deficits in major depressive disorder (MDD). The rs2187473 polymorphism may be a genetic risk factor for cognitive dysfunction in MDD patients.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Major depressive disorder (MDD) is associated with cognitive impairments.
- MicroRNAs (miRNAs) play a role in the etiology of MDD.
- Genetic factors influence cognitive dysfunction in MDD.
Purpose of the Study:
- To investigate the impact of miR-34b/c expression and genetic variation on cognitive dysfunction in MDD.
- To analyze the relationship between miR-34c-5p levels and cognitive performance.
- To assess the association of MIR34B/C gene polymorphisms with cognitive function in MDD patients.
Main Methods:
- qRT-PCR was used to measure miR-34c-5p expression in MDD patients and controls.
- Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Trail Making Test (TMT).
- Genetic association analysis of MIR34B/C single-nucleotide polymorphism (SNP) loci was performed.
Main Results:
- miR-34c-5p expression negatively correlated with language and delayed memory scores in MDD.
- Higher miR-34c-5p levels correlated with longer completion times for TMT A and B.
- The rs2187473 genotype showed significant interaction with MDD for immediate and delayed memory, with the CC genotype associated with better performance.
Conclusions:
- Altered miR-34c expression significantly impacts cognitive function in MDD.
- The miR-34b/c polymorphism rs2187473 is a potential genetic risk factor for cognitive impairment in MDD.
- These findings may have clinical implications for managing cognitive dysfunction in MDD.
Related Concept Videos
MicroRNAs
MicroRNAs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

